Sign up to our newsletter Subscribe

All Topics
Health Technology Assessment (HTA)
Antimicrobial Resistance (AMR)

Newsletter SignupSubscribe

Search publications, topics, authors and more

News & Insights

News
Events
Insights
Bulletin

News
Events
Insights
Bulletin

Sign up to our newsletter Subscribe

News & Insights

News
Events
Insights
Bulletin

Newsletter SignupSubscribe

News
Events
Insights
Bulletin

Search publications, topics, authors and more

Close

Research & Publications
News & Insights
Education
Innovation Policy Prize

Events
About Us
OHE Experts
Join OHE
Contact Us

Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:

Antimicrobial Resistance (AMR)
Biosimilars
Cell and Gene Therapies
Chronic Diseases
Combination Therapies
COVID-19 Research
Digital Health
Drug Development/R&D
Emerging Markets
EQ-5D and PROMs
Indication-Based Pricing
Health Care Systems
Health Data and Statistics
Health Technology Assessment
Precision Medicine
Prevention
Real-World Evidence
Sustainability
Use of Medicines
Value-Based Pricing
Vaccine Research

Economics of Innovation
Measuring and Valuing Outcomes
Policy, Organisation and Incentives in Health Systems
Value, Affordability and Decision Making

News & Insights

News
Events
Insights
Bulletin

Education

Education Hub
OHE Graduate School
EVIA Programme

Innovation Policy Prize

The Prize Fund
2024 Prize Fund
2022 Prize Fund

Search publications, topics, authors and more

Latest Research & Publications

Antimicrobial Resistance (AMR)
Value, Affordability, and…

Proposals for a Novel UK Antimicrobial Subscription Model: The Investor Perspective

Read more

Health Care Systems
Policy, Organisation and…
Economic Evaluation

Reimagining Prevention for a Healthier, More Prosperous Society

Read more

Health Technology Assessment…
Israel

NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

Read more

Cell and Gene Therapies
Value, Affordability, and…
Gene therapies

Are Recommendations for HTA of Gene Therapies Being Achieved?

Read more

Chronic Diseases
Value, Affordability, and…
Dermatology

The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society

Read more

Dementia
Economics of Innovation
Alzheimer's

Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment

Read more

Antimicrobial Resistance (AMR)
Economics of Innovation

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Read more

Health Technology Assessment…
Value, Affordability, and…
Pricing and Reimbursement

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

Read more

01
02
03
04
05
06
07
08
00

Close

All Publications

Filter by:

Antimicrobial Resistance (AMR)

Biosimilars

Cell and Gene Therapies

Chronic Diseases

Combination Therapies

COVID-19 Research

Digital Health

Drug Development/R&D

Emerging Markets

EQ-5D and PROMs

Indication-Based Pricing

Health Care Systems

Health Data and Statistics

Health Technology Assessment

Precision Medicine

Prevention

Real-World Evidence

Sustainability

Use of Medicines

Value-Based Pricing

Vaccine Research

Economics of Innovation

Measuring and Valuing Outcomes

Policy, Organisation and Incentives in Health Systems

Value, Affordability and Decision Making
News

Events

Insights

Bulletin
Education Hub

OHE Graduate School

EVIA Programme
The Prize Fund

2024 Prize Fund

2022 Prize Fund

Events
About Us
OHE Experts
Join OHE
Contact Us

Newsletter SignupSubscribe

OHE Newsroom

Comment, press releases and other news from OHE.

Graduate school

News
November 2024

Applications open for MSc Fellowship Programme 2025

A switch to vegan diets could save the NHS £6.7 billion per year, new research reveals

News
January 2024

A switch to vegan diets could save the NHS £6.7 billion per year, new research reveals

Filter results by

Topic

Select the product option you would like to filter Topic

Antimicrobial Resistance (AMR) Biosimilars Cell and Gene Therapies Chronic Diseases Combination Therapies COVID-19 Research Dementia Digital Health Drug Development/R&D Emerging Markets EQ-5D and PROMs Health Care Systems Health Data and Statistics Health Technology Assessment (HTA) Indication-Based Pricing Innovation Policy Prize OHE Consulting Precision Medicine Prevention Real World Evidence (RWE) Research Sustainability Use of Medicines Vaccines Value-Based Pricing

Date 1

Select the product option you would like to filter Date

Date From

Month From

Year From

Date To

Month To

Year To

News
August 2020

Are Discount Rates Used in UK Vaccine Economic Evaluations Jeopardising Investment in Immunisation Programmes?

News
July 2020

NICE ‘Optimised’ Recommendations: What Do They Mean for Patient Access?

News
June 2020

The 2020 OHE Annual Lecture Explores the Question: How Should the World Pay for a COVID-19 Vaccine?

Danzon_Patricia_1305 (1)

News
June 2020

Victor R. Fuchs Award for 2020 Goes to Patricia Danzon

News
June 2020

OHE Authors Develop a Supply and Demand Model of Pharmaceutical Markets to Set Cost-Effectiveness Thresholds to Maximise and Distribute Social Welfare

News
May 2020

OHE Awarded Independent Research Organisation (IRO) Status by UKRI

News
May 2020

Indication-Based Pricing: Are We All Onboard?

News
April 2020

Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment—Rationale and Empirical Support

News
April 2020

Financing and Scaling Innovation for the COVID Fight: A Closer Look at Demand-Side Incentives for a Vaccine

News
March 2020

How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.

News
March 2020

Price Transparency: Good or Bad? What Does Literature and Theory Tell Us?

News
March 2020

Are Cost-Effectiveness Thresholds Fit for Purpose for Real-World Decision Making on Access to and Pricing of Pharmaceuticals? A New OHE Paper on Current Methods and Practices, and a Novel Approach for Optimal Thresholds

01
02
03
04
05
06
07
08
00

Subscribe To Our Newsletter

Our monthly Bulletin highlights our work alongside the latest from across health economics and health care.

Sign Up Now

Leading intellectual authority on global health economics

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

© 2025 Website Design

An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Share on Mastodon

Enter your Mastodon instance URL (optional)

Powered by GDPR Cookie Compliance

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Enable or Disable Cookies

Please enable Strictly Necessary Cookies first so that we can save your preferences!